SARS-CoV2 in a Lupus Patient Treated With Hydroxychloroquine SARS-CoV2 in a Lupus Patient Treated With Hydroxychloroquine
Was this COVID-19 patient ' s decreased immune response a result of his being treated with hydroxychloroquine for lupus?Journal of Medical Case Reports (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - December 21, 2021 Category: Intensive Care Tags: Family Medicine/Primary Care Journal Article Source Type: news

An Engineer ’s Perspective on Autoimmunity
Erika Moore builds biomaterials to study disparate lupus outcomes. (Source: The Scientist)
Source: The Scientist - December 10, 2021 Category: Science Tags: Sponsored Article Source Type: news

How Long Can You Live With Lupus Nephritis?
Title: How Long Can You Live With Lupus Nephritis?Category: Diseases and ConditionsCreated: 12/9/2021 12:00:00 AMLast Editorial Review: 12/9/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - December 9, 2021 Category: Nutrition Source Type: news

SLE Treatment Updates From ACR 2021 SLE Treatment Updates From ACR 2021
Systemic lupus erythematosus updates from ACR 2021 are discussed by Dr Joan Merrill, who reviews data on a novel agent, a post-hoc analysis of BLISS-LN, and late-breaking BLISS-BELIEVE results.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 30, 2021 Category: Consumer Health News Tags: None ReCAP Source Type: news

Adding Rituximab to Belimumab Offers No Help for Lupus Adding Rituximab to Belimumab Offers No Help for Lupus
The combination of rituximab and belimumab was associated with a longer duration of response, but there was no benefit of belimumab alone for disease control at 1 year.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 15, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

Lupus in Remission Flares More Often When Reducing, Stopping HCQ Lupus in Remission Flares More Often When Reducing, Stopping HCQ
It ' s clear that more flares occur when patients in remission or low disease activity stop or reduce hydroxychloroquine, but it ' s important to consider this effect in different age groups, too.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 9, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Distinct Molecular Signatures for Subsets of Patients With CLE Distinct Molecular Signatures for Subsets of Patients With CLE
The findings of this study support a diverse molecular profile in cutaneous lupus erythematosus, opening the door for targeted therapies for different subsets of patients with the disease.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 20, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Aspirin Lowered Preeclampsia Risk in Real-World Lupus Study Aspirin Lowered Preeclampsia Risk in Real-World Lupus Study
A prospective, single-center study of pregnancies during 1995 –2020 showed a reduced risk for preeclampsia among high-risk women with systemic lupus erythematous who received low-dose aspirin.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 19, 2021 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

' Multimorbidity' More Commonly Seen in People With Lupus'Multimorbidity' More Commonly Seen in People With Lupus
Two studies find that patients with either systemic or cutaneous disease have higher rates of multiple comorbidities, including those commonly reported before and those less frequently associated.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 19, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

Lupus sufferers pleaded for hydroxychloroquine before Clive Palmer ’s doses were destroyed
Drug ’s potential as Covid treatment, since dispelled, affected availability for people with proven medical needGet our free news app;get our morning email briefingLupus sufferers pleaded for more supplies of hydroxychloroquine two months before the federal government told billionaire Clive Palmer it didn ’t want more of the 33m doses he wanted to donate as a potential Covid-19 treatment.One tonne of Palmer ’s hydroxychloroquine – equivalent to 5m doses – was destroyed after it was left unclaimed in Melbourne due to a lengthy standoff with the commonwealth, Guardian Australiarevealed on Wednesday.Sign up to recei...
Source: Guardian Unlimited Science - October 14, 2021 Category: Science Authors: Christopher Knaus Tags: Clive Palmer Australia news Health Coronavirus Medical research Source Type: news

What Are the Symptoms of Lupus in a Woman
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 14, 2021 Category: General Medicine Source Type: news

Lupus May Confer Higher Risk of Death From COVID-19 Lupus May Confer Higher Risk of Death From COVID-19
SLE had a greater impact on mortality and other poor outcomes than all the other comorbidities considered in a cross-sectional study of patients with COVID-19 in Brazil.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 14, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Lupus & cora 2021 lupus & cora 2021
Read clinically focused news coverage of key developments from LUPUS& CORA 2021.Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 11, 2021 Category: Consumer Health News Tags: None Conference Coverage Source Type: news

LUPUS and CORA 2021 LUPUS and CORA 2021
Read clinically focused news coverage of key developments from LUPUS& CORA 2021.Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 11, 2021 Category: Rheumatology Tags: Rheumatology Conference Coverage Source Type: news